Delamanid for multidrug-resistant pulmonary tuberculosis

被引：0
|
作者：
Beltran Romero, L. M. [1 ]
机构：
[1] Hosp Univ La Paz, Med Interna Serv, Madrid, Spain
来源：
REVISTA CLINICA ESPANOLA | 2012年 / 212卷 / 10期
关键词：
D O I：
10.1016/j.rce.2012.07.014
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：499 / 500
页数：2
相关论文
共 50 条
  • [1] Delamanid for Multidrug-Resistant Pulmonary Tuberculosis
    Gler, Maria Tarcela
    Skripconoka, Vija
    Sanchez-Garavito, Epifanio
    Xiao, Heping
    Cabrera-Rivero, Jose L.
    Vargas-Vasquez, Dante E.
    Gao, Mengqiu
    Awad, Mohamed
    Park, Seung-Kyu
    Shim, Tae Sun
    Suh, Gee Young
    Danilovits, Manfred
    Ogata, Hideo
    Kurve, Anu
    Chang, Joon
    Suzuki, Katsuhiro
    Tupasi, Thelma
    Koh, Won-Jung
    Seaworth, Barbara
    Geiter, Lawrence J.
    Wells, Charles D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (23): : 2151 - 2160
  • [2] Delamanid in the treatment of multidrug-resistant tuberculosis
    Gupta, R.
    Wells, C. D.
    Hittel, N.
    Hafkin, J.
    Geiter, L. J.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2016, 20 (12) : S33 - S37
  • [3] Population Pharmacokinetic Analysis of Delamanid in Patients with Pulmonary Multidrug-Resistant Tuberculosis
    Wang, Xiaofeng
    Mallikaarjun, Suresh
    Gibiansky, Ekaterina
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (01)
  • [4] Profile of delamanid for the treatment of multidrug-resistant tuberculosis
    Szumowski, John D.
    Lynch, John B.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 677 - 682
  • [5] Treatment of multidrug-resistant pulmonary tuberculosis with delamanid based on Japanese guideline recommendations
    Okumura, Masao
    Yoshiyama, Takashi
    Ogata, Hideo
    Kurashima, Atsuyuki
    Yoshimori, Kozo
    Ohta, Ken
    Kudoh, Shoji
    RESPIRATORY INVESTIGATION, 2020, 58 (02) : 110 - 116
  • [6] Outcomes of Multidrug-Resistant Tuberculosis Treated With Bedaquiline or Delamanid
    Hwang, Hyeontaek
    Kang, Hyungseok
    Kwon, Yong-Soo
    Jeon, Doosoo
    Shim, Tae Sun
    Yim, Jae-Joon
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (08) : 1362 - 1369
  • [7] Delamanid and QT prolongation in the treatment of multidrug-resistant tuberculosis
    Gupta, Rajesh
    Getter, Lawrence J.
    Hafkin, Jeffrey
    Wells, Charles D.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2015, 19 (10) : 1261 - 1262
  • [8] Delamanid: A Review of Its Use in Patients with Multidrug-Resistant Tuberculosis
    Blair, Hannah A.
    Scott, Lesley J.
    DRUGS, 2015, 75 (01) : 91 - 100
  • [9] Delamanid in multidrug-resistant tuberculosis: a guide to its use in the EU
    Lyseng-Williamson K.A.
    Blair H.A.
    Scott L.J.
    Drugs & Therapy Perspectives, 2015, 31 (11) : 378 - 384
  • [10] Delamanid as an Add-on for treating Patients with multidrug-resistant Tuberculosis
    Meinrenken, Susanne
    PNEUMOLOGIE, 2019, 73 (04): : 205 - 205
12345